Skip to content

688687.SH

凯因科技

SSE · Healthcare · Biotechnology · CN

CNY 18.05
−0.72%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue1.3B1.3B1.2B1.4B1.2B
Cost of Revenue252.1M235.7M223.0M232.3M155.4M
Gross Profit1.0B1.1B1.0B1.2B1.0B
Operating Expenses
R&D Expense143.4M140.9M138.2M134.2M114.2M
SG&A Expense
General & Admin Expense140.0M128.1M114.9M102.9M137.2M
Selling & Marketing Expense606.1M629.3M597.5M793.4M716.0M
Other Expenses
Total Operating Expenses903.2M908.3M842.8M1.0B954.1M
Cost and Expenses1.2B1.1B1.1B1.3B1.1B
Operating Income (EBIT)41.8M67.4M193.0M170.8M106.5M
Non-Operating
Interest Income
Interest Expense
Net Interest Income
Other Non-Op Income/Expense
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)30.1M53.7M176.8M146.2M97.7M
Income Tax Expense10.4M13.5M17.7M9.0M17.1M
Bottom Line
Net Income11.1M30.6M142.4M116.5M83.4M
Earnings from Cont. Ops19.7M40.3M159.2M137.3M80.6M
Earnings from Discont. Ops
Bottom Line Net Income11.1M30.6M142.4M116.5M83.4M
Per Share
Basic EPSCN¥0.07CN¥0.18CN¥0.85CN¥0.70CN¥0.49
Diluted EPSCN¥0.07CN¥0.18CN¥0.85CN¥0.70CN¥0.49
Revenue Per ShareCN¥8.45CN¥7.77CN¥7.35CN¥8.48CN¥6.81
Shares
Basic Shares Outstanding153.4M170.0M167.5M166.5M170.2M
Diluted Shares Outstanding153.4M170.0M167.5M166.5M170.2M
Profitability Metrics
EBITDA120.6M236.4M209.5M143.5M
D&A53.3M43.4M38.6M37.0M
EBIT

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026